Amryt Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Amryt Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $222,543,000. The net income raised on -$18,171,000 and profit margin reached -8%. Total operating expenses were $138,065,000.
Profit Margin
| 2012 | 0 | -826.11K | |
|---|---|---|---|
| 2013 | 0 | -2.11M | |
| 2014 | 0 | -2.55M | |
| 2015 | 0 | -39.74M | |
| 2016 | 1.42M | -8.20M | -577.65% |
| 2017 | 15.32M | -45.66M | -297.89% |
| 2018 | 16.53M | -29.48M | -178.34% |
| 2019 | 58.12M | -65.53M | -112.75% |
| 2020 | 182.60M | -104.52M | -57.24% |
| 2021 | 222.54M | -18.17M | -8.17% |
AMYT Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 222.54M | 182.60M | 58.12M | 16.53M | 15.32M | 1.42M | 0 | 0 | 0 | 0 |
Cost of revenue | 106.11M | 119.02M | 42.00M | 6.06M | 6.44M | 616.29K | 0 | 0 | 0 | 0 |
Gross profit | 116.42M | 63.57M | 16.12M | 10.47M | 8.88M | 804.55K | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 37.72M | 27.61M | 15.82M | 10.35M | 12.67M | 2.46M | 0 | 0 | 0 | 0 |
Selling and marketing | 91.99M | 76.67M | 35.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 138.06M | 109.02M | 52.16M | 27.91M | 25.92M | 6.95M | 3.33M | 2.93M | 1.85M | 275.37K |
Operating income | -21.64M | -45.44M | -36.04M | -17.44M | -17.04M | -8.08M | -39.93M | -2.93M | -3.50M | -275.37K |
Other income (expenses), net | -8.17M | -60.41M | -30.71M | -12.00M | -14.31M | -127.25K | 189K | -36.80M | 1.39M | 0 |
Income before tax | -29.81M | -105.85M | -66.76M | -29.44M | -31.35M | -8.20M | -39.74M | -2.55M | -2.11M | -275.37K |
Income tax expense | -11.64M | -1.33M | -1.22M | 41.18K | 14.31M | 1.93M | 73.18M | -175K | 2.23M | 0 |
Net income | -18.17M | -104.52M | -65.53M | -29.48M | -45.66M | -8.20M | -39.74M | -2.55M | -2.11M | -826.11K |
Earnings per share | ||||||||||
Basic EPS | -0.39 | -2.92 | -4.32 | -3.22 | -6.14 | -1.51 | -3.45 | -0.26 | -0.33 | -0.08 |
Diluted EPS | -0.37 | -2.92 | -4.32 | -3.22 | -6.14 | -1.51 | -3.45 | -0.26 | -0.33 | -0.08 |
| Data source | Data source |